Search
for
Sort by
Research 721–750 of 1000+
- Telogen effluvium. New possibilities of correction
- Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction
- <i>Serenoa repens</i> as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report
- Topically applied glycyrrhizic acid causes hair removal in rats
- Evaluation of efficacy, safety, and reversibility of combination regimen of cyproterone acetate and testosterone buciclate in bonnet monkey
- Oral itraconazole for the treatment of giant tufted angioma with hair loss arising during pregnancy: A case report
- Comparison of the impact of intermittent fasting diet alone or in conjunction with probiotic supplementation versus calorie-restricted diet on inflammatory, oxidative stress, and antioxidant capacity biomarkers in women with polycystic ovary syndrome: A randomized placebo-controlled trial
- Skin and Scalp Health Benefits of a Specific Botanical Extract Blend: Results from a Double-Blind Placebo-Controlled Study in Urban Outdoor Workers
- Attenuation of disease process following treatment with low-dose naltrexone in patients with frontal fibrosing alopecia and lichen planopilaris: A retrospective study
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Topical Calcipotriol versus oral vitamin D in the treatment of alopecia areata
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Bimatoprost
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?
- The Belgian Ten‐Center Open Label Trial of Topical 2% Minoxidil Solution in Early Male Pattern Alopecia
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial
- Tinea Capitis In Adolescent: A Case Report
- Hair Shedding Evaluation for Alopecia: A Refined Wash Test
- Flagellate Shiitake Mushroom Reaction With Histologic Features of Acute Generalized Exanthematous Pustulosis
- Moxibustion improves ovarian function based on the regulation of the androgen balance
- The prescribing cascade 3.0: a case for recreational drugs in HIV
- Terazosin or baclofen in young men with chronic orchialgia: A cohort study of 499 patients
- Biotin
- Epilepsy and Neurodegeneration: Clues in the Hair and Blood Vessels!
- Study of effect of myoinositol on menstrual irregularities and skin problems in polycystic ovarian syndrome cases
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata